ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001446125

Greenstreet Yvonne

CIK 0001446125 Name as filed on the most recent filing

Filed as Greenstreet Yvonne (29)

163 transaction lines · from 29 filings · filed 2018-03-28 to 2026-03-06 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

163 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 973 disposed 323.84 315,096.32 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 444 disposed 323.01 143,416.44 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 368 disposed 321.82 118,429.76 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 345 disposed 324.88 112,083.60 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 274 disposed 320.81 87,901.94 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 265 disposed 325.67 86,302.55 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 135 disposed 319.03 43,069.05 Form 4, filing 0001735276-26-000062
2026-03-04 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 129 disposed 320.01 41,281.29 Form 4, filing 0001735276-26-000062
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,669 disposed 326.81 545,445.89 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,399 disposed 327.67 458,410.33 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,098 disposed 325.63 357,541.74 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 722 disposed 329.71 238,050.62 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 424 disposed 328.71 139,373.04 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 399 disposed 331.93 132,440.07 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 382 disposed 324.65 124,016.30 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 346 disposed 330.85 114,474.10 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 200 disposed 323.62 64,724.00 Form 4, filing 0001735276-26-000048
2026-03-02 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 160 disposed 332.64 53,222.40 Form 4, filing 0001735276-26-000048
2026-02-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 6,958 disposed 310.08 2,157,542.21 Form 4, filing 0001735276-26-000028
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,395 disposed 365.56 509,956.20 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,259 disposed 364.83 459,320.97 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 980 disposed 360.22 353,015.60 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 778 disposed 358.18 278,664.04 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 624 disposed 361.45 225,544.80 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 607 disposed 357.17 216,802.19 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 584 disposed 368.62 215,274.08 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 537 disposed 359.14 192,858.18 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 464 disposed 362.38 168,144.32 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 316 disposed 366.41 115,785.56 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 301 disposed 363.55 109,428.55 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 269 disposed 355.16 95,538.04 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 263 disposed 356.09 93,651.67 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 261 disposed 367.40 95,891.40 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 253 disposed 369.48 93,478.44 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 247 disposed 353.95 87,425.65 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 118 disposed 375.65 44,326.70 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 118 disposed 370.87 43,762.66 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 94 disposed 377.82 35,515.08 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 88 disposed 374.44 32,950.72 Form 4, filing 0001735276-26-000014
2026-01-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 21 disposed 372.46 7,821.66 Form 4, filing 0001735276-26-000014
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 2,218 disposed 450.69 999,630.42 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,702 disposed 451.94 769,201.88 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,599 disposed 452.85 724,107.15 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,477 disposed 450.02 664,679.54 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 1,013 disposed 448.76 454,593.88 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 881 disposed 453.99 399,965.19 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 654 disposed 447.73 292,815.42 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 261 disposed 456.03 119,023.83 Form 4, filing 0001735276-25-000120
2025-11-13 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 195 disposed 454.69 88,664.55 Form 4, filing 0001735276-25-000120
2025-11-12 Alnylam Pharmaceuticals, Inc.
ALNY 		S, Open-market sale 3,406 disposed 455.56 1,551,637.36 Form 4, filing 0001735276-25-000120

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 163
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Greenstreet Yvonne, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001446125

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.